CGT9486
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CGT9486, covering 2025-02-14 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis [Phase 2]